FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Manufacturer

Country

Registration Date 9 Aug 2018
Revision Date 9 Aug 2018
Share

NLAB Silica

(0)

Medicine Pharmaceuticals

Nanoporous silica

Nanomaterials

Manufacturer Asserted

Silicon dioxide

SiO2 Nanoporous CAS Number : 7631-86-9

Applications

Nanologica’s porous amorphous silica encapsulates compounds to enhance solubility and efficacy in novel pharmaceutical formulations.
Drug delivery

Properties

Improved delivery of APIs High solubility

Manufacturer's Description

In the Drug Delivery business area, Nanologica develops nanoporous silica, NLAB SilicaTM, for the improved delivery of Active Pharmaceutical Ingredients (APIs) in oral dosage form. Up to 90% of oral medicines in development today suffer from low oral solubility. This can compromise the efficacy and safety of new drug compounds leading to poor patient response and prohibit further drug development. Nanologica uses its extensive knowledge of interactions between APIs and the materials in its broad NLAB SilicaTM portfolio in order to develop new pharmaceutical formulations with dramatic improvement in solubility, stability and handling.